ESR1 and breast carcinoma: In breast cancer cells, Orai1 and TRPC6 are upregulated in the estrogen receptor positive (ER+) and triple negative subtypes, and Orai3 is overexpressed exclusively in the ER+ breast cancer subtype [9,10].